We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 12th August, 2022 at 3:00 pm had considered and approved the following items of Business:
1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2022; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company; copies of which are attached hereunder;
The Meeting of the Board Commenced at 3:00 P.M. and concluded at 06:50 P.M.
Kindly oblige and take the same on your Records.
|